Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/36058
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTANG, Karen T. Y.
dc.contributor.authorKIM, Hyoun S.
dc.contributor.authorHODGINS, David C.
dc.contributor.authorMCGRATH, Daniel S.
dc.contributor.authorTAVARES, Hermano
dc.date.accessioned2020-06-01T14:57:30Z-
dc.date.available2020-06-01T14:57:30Z-
dc.date.issued2020
dc.identifier.citationPSYCHIATRY RESEARCH, v.284, article ID 112763, 8p, 2020
dc.identifier.issn0165-1781
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/36058-
dc.description.abstractGambling disorder (GD) frequently co-occurs with substance use disorders. However, the extent to which GD co-occurs with behavioral addictions (BAs) and the demographic, clinical, and personality correlates of comorbid GD and BA is largely unknown. The aims of the present research were to address this gap among people seeking treatment for GD (N = 458) in Sao Paulo, Brazil. Structured clinical interviews diagnosed individuals with GD and other psychiatric disorders. The Shorter PROMIS questionnaire was used to identify BAs (work, exercise, food bingeing, sex, and shopping). Questionnaires assessed demographic characteristics, gambling behavior, and personality. Of the total sample, 206 (45.0%) participants met the criteria of having at least one behavioral addiction (GD+BA). The most common comorbid BA was food bingeing (8.1%) with the least common being exercise (3.6%). In a multivariate logistic regression, individuals with GD + BA tended to be younger, and had greater rates of comorbid post-traumatic stress disorder and bulimia nervosa compared to participants who did not present with a comorbid BA. Taken together, individuals with GD + BA present with increased psychopathology. These results may have important implications for the assessment and treatment of individuals with GD and comorbid BAs.eng
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTDeng
dc.relation.ispartofPsychiatry Research
dc.rightsrestrictedAccesseng
dc.subjectGambling disordereng
dc.subjectWork addictioneng
dc.subjectExercise addictioneng
dc.subjectBinge eating addictioneng
dc.subjectSex addictioneng
dc.subjectShopping addictioneng
dc.subject.othersubstance use disorderseng
dc.subject.otherposttraumatic-stress-disordereng
dc.subject.otherimpulse control disorderseng
dc.subject.otherpsychiatric co-morbidityeng
dc.subject.otherquality-of-lifeeng
dc.subject.otherpathological gamblerseng
dc.subject.othereating-disordereng
dc.subject.otherexercise addictioneng
dc.subject.othervalidationeng
dc.subject.otherprevalenceeng
dc.titleGambling disorder and comorbid behavioral addictions: Demographic, clinical, and personality correlateseng
dc.typearticleeng
dc.rights.holderCopyright ELSEVIER IRELAND LTDeng
dc.identifier.doi10.1016/j.psychres.2020.112763
dc.identifier.pmid31951870
dc.subject.wosPsychiatryeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalTANG, Karen T. Y.:Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada
hcfmusp.author.externalKIM, Hyoun S.:Univ Calgary, Dept Psychol, Calgary, AB, Canada
hcfmusp.author.externalHODGINS, David C.:Univ Calgary, Dept Psychol, Calgary, AB, Canada
hcfmusp.author.externalMCGRATH, Daniel S.:Univ Calgary, Dept Psychol, Calgary, AB, Canada
hcfmusp.description.articlenumber112763
hcfmusp.description.volume284
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000517664400021
hcfmusp.origem.id2-s2.0-85077739153
hcfmusp.publisher.cityCLAREeng
hcfmusp.publisher.countryIRELANDeng
hcfmusp.relation.referenceAbdollahnejad R, 2014, ADDICT BEHAV, V39, P566, DOI 10.1016/j.addbeh.2013.11.004eng
hcfmusp.relation.referenceAlvarez-Moya EM, 2010, CAN J PSYCHIAT, V55, P498, DOI 10.1177/070674371005500804eng
hcfmusp.relation.referenceAmorim P., 2000, REV BRAS PSIQUIATR, V22, P106, DOI 10.1590/S1516-44462000000300003eng
hcfmusp.relation.referenceAndreassen CS, 2012, SCAND J PSYCHOL, V53, P265, DOI 10.1111/j.1467-9450.2012.00947.xeng
hcfmusp.relation.reference[Anonymous], 2013, DIAGN STAT MAN MENTeng
hcfmusp.relation.referenceArgo T.R., 2004, PATHOLOGICAL GAMBLINeng
hcfmusp.relation.referenceBack S, 2000, AM J ADDICTION, V9, P51eng
hcfmusp.relation.referenceBarnes GM, 2011, AM J ADDICTION, V20, P166, DOI 10.1111/j.1521-0391.2010.00116.xeng
hcfmusp.relation.referenceBlack DW, 1997, AM J PSYCHIAT, V154, P243eng
hcfmusp.relation.referenceBottesi G, 2015, J GAMBL STUD, V31, P825, DOI 10.1007/s10899-014-9470-5eng
hcfmusp.relation.referenceBrady KT, 2004, CURR DIR PSYCHOL SCI, V13, P206, DOI 10.1111/j.0963-7214.2004.00309.xeng
hcfmusp.relation.referenceBrown VB, 1999, J PSYCHOACTIVE DRUGS, V31, P31, DOI 10.1080/02791072.1999.10471723eng
hcfmusp.relation.referenceBrown VB, 2013, J PSYCHOACTIVE DRUGS, V45, P386, DOI 10.1080/02791072.2013.844381eng
hcfmusp.relation.referenceCalado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073eng
hcfmusp.relation.referenceCarlotta D, 2015, J PERS DISORD, V29, P378, DOI 10.1521/pedi_2014_28_164eng
hcfmusp.relation.referenceChristo G, 2003, ADDICT BEHAV, V28, P225, DOI 10.1016/S0306-4603(01)00231-3eng
hcfmusp.relation.referenceCiccarelli M, 2020, J GAMBL STUD, V36, P243, DOI 10.1007/s10899-019-09872-xeng
hcfmusp.relation.referenceClaus RE, 2002, J PSYCHOACTIVE DRUGS, V34, P25, DOI 10.1080/02791072.2002.10399933eng
hcfmusp.relation.referenceCloninger C. R., 1999, TEMPERAMENT CHARACTEeng
hcfmusp.relation.referenceCowie ME, 2019, J BEHAV ADDICT, V8, P451, DOI 10.1556/2006.8.2019.35eng
hcfmusp.relation.referenceMarques JMD, 2008, GEN HOSP PSYCHIAT, V30, P303, DOI 10.1016/j.genhosppsych.2008.02.001eng
hcfmusp.relation.referencede Mattos CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167365eng
hcfmusp.relation.referenceDegenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0eng
hcfmusp.relation.referenceDel Pino-Gutierrez A, 2017, J BEHAV ADDICT, V6, P396, DOI 10.1556/2006.6.2017.051eng
hcfmusp.relation.referenceDellOsso B., 2005, CLIN PR EPIDEMOL MEN, V1, P54eng
hcfmusp.relation.referenceDowling NA, 2015, AUST NZ J PSYCHIAT, V49, P519, DOI 10.1177/0004867415575774eng
hcfmusp.relation.referenceDwyer R, 2016, HEALTH SOCIOL REV, V25, P223, DOI 10.1080/14461242.2016.1184581eng
hcfmusp.relation.referenceFernandez-Aranda F, 2019, J BEHAV ADDICT, V8, P123, DOI 10.1556/2006.8.2019.08eng
hcfmusp.relation.referenceFrascella J, 2010, ANN NY ACAD SCI, V1187, P294, DOI 10.1111/j.1749-6632.2009.05420.xeng
hcfmusp.relation.referenceFuentes D., 2000, ESCALAS AVALIACAO CL, P363eng
hcfmusp.relation.referenceGaletti AM, 2017, REV BRAS PSIQUIATR, V39, P36, DOI 10.1590/1516-4446-2016-1911eng
hcfmusp.relation.referenceGrant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184eng
hcfmusp.relation.referenceGrant JE, 2005, COMPR PSYCHIAT, V46, P34, DOI 10.1016/j.comppsych.2004.07.022eng
hcfmusp.relation.referenceGrant JE, 2003, ACTA PSYCHIAT SCAND, V108, P203, DOI 10.1034/j.1600-0447.2003.00162.xeng
hcfmusp.relation.referenceGrant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884eng
hcfmusp.relation.referenceGrant JE, 2005, SEX ADDICT COMPULS, V12, P235, DOI 10.1080/10720160500203856eng
hcfmusp.relation.referenceGuerrero-Vaca D, 2019, J GAMBL STUD, V35, P261, DOI 10.1007/s10899-018-9786-7eng
hcfmusp.relation.referenceGuo K, 2017, ADDICT BEHAV, V67, P26, DOI 10.1016/j.addbeh.2016.11.021eng
hcfmusp.relation.referenceHall GW, 2000, AM J PSYCHIAT, V157, P1127, DOI 10.1176/appi.ajp.157.7.1127eng
hcfmusp.relation.referenceHaro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196eng
hcfmusp.relation.referenceHodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-Xeng
hcfmusp.relation.referenceJacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184eng
hcfmusp.relation.referenceJaniri L, 2007, SUBST USE MISUSE, V42, P975, DOI 10.1080/10826080701202445eng
hcfmusp.relation.referenceKessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900eng
hcfmusp.relation.referenceKim HS, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00406eng
hcfmusp.relation.referenceKim HS, 2018, EUR EAT DISORD REV, V26, P508, DOI 10.1002/erv.2606eng
hcfmusp.relation.referenceKim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008eng
hcfmusp.relation.referenceLadd GT, 2003, EXP CLIN PSYCHOPHARM, V11, P202, DOI 10.1037/1064-1297.11.3.202eng
hcfmusp.relation.referenceLichtenstein MB, 2014, PSYCHIAT RES, V215, P410, DOI 10.1016/j.psychres.2013.11.010eng
hcfmusp.relation.referenceLorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.xeng
hcfmusp.relation.referenceMalloy-Diniz L.F., 2010, J BRAS PSIQUIAT, V59, P99, DOI 10.1590/S0047-20852010000200004eng
hcfmusp.relation.referenceMaraz A, 2016, ADDICTION, V111, P408, DOI 10.1111/add.13223eng
hcfmusp.relation.referenceMerikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8eng
hcfmusp.relation.referenceMonok K, 2012, PSYCHOL SPORT EXERC, V13, P739, DOI 10.1016/j.psychsport.2012.06.003eng
hcfmusp.relation.referenceMustelin L, 2017, APPETITE, V109, P165, DOI 10.1016/j.appet.2016.11.032eng
hcfmusp.relation.referencePatton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1eng
hcfmusp.relation.referencePetry NM, 2003, J NERV MENT DIS, V191, P399, DOI 10.1097/01.NMD.0000071589.20829.DBeng
hcfmusp.relation.referencePreti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003eng
hcfmusp.relation.referenceRead JP, 2014, PSYCHOL ADDICT BEHAV, V28, P1052, DOI 10.1037/a0038348eng
hcfmusp.relation.referenceSchaffer S D, 1990, Nurse Pract, V15, P25eng
hcfmusp.relation.referenceSlutske WS, 2005, ARCH GEN PSYCHIAT, V62, P769, DOI 10.1001/archpsyc.62.7.769eng
hcfmusp.relation.referenceSouza T., 2008, BEHAV ANAL TODAY, V9, P11, DOI 10.1037/H0100643eng
hcfmusp.relation.referenceSteenbergh TA, 2002, PSYCHOL ADDICT BEHAV, V16, P143, DOI 10.1037//0893-164X.16.2.143eng
hcfmusp.relation.referenceSterling S, 2011, ALCOHOL RES HEALTH, V33, P338eng
hcfmusp.relation.referenceSussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI [10.1177/0163278710380124, 10.1177/0163278709360274]eng
hcfmusp.relation.referenceSzabo A., 2007, INT J MENT HEALTH AD, V5, P25, DOI 10.1007/S11469-006-9050-8eng
hcfmusp.relation.referenceTabachnick B.G., 2012, USING MULTIVARIATE S, DOI [10.1037/022267, DOI 10.1037/022267]eng
hcfmusp.relation.referenceTavares H, 2003, J CLIN PSYCHIAT, V64, P433, DOI 10.4088/JCP.v64n0413eng
hcfmusp.relation.referenceWinters Ken C, 2003, J Gambl Stud, V19, P261, DOI 10.1023/A:1024203403982eng
hcfmusp.relation.referenceWorld Health Organization, 2018, INT CLASS DIS 11 REVeng
hcfmusp.relation.referenceYakovenko I, 2018, INT GAMBL STUD, V18, P143, DOI 10.1080/14459795.2017.1364400eng
hcfmusp.relation.referenceYucel M, 2019, ADDICTION, V114, P1095, DOI 10.1111/add.14424eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus9-
hcfmusp.scopus.lastupdate2022-04-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPS
Departamento de Psiquiatria - FM/MPS

Artigos e Materiais de Revistas Científicas - LIM/23
LIM/23 - Laboratório de Psicopatologia e Terapêutica Psiquiátrica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_TANG_Gambling_disorder_and_comorbid_behavioral_addictions_Demographic_clinical_2020.PDF
  Restricted Access
publishedVersion (English)483.35 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.